Cat. No. 5774
Chemical Name: N-[2,3-Dihydro-3-[(5-methoxy-1H-ind
Biological ActivityERK dimerization inhibitor (IC50 ~ 0.5 μM); inhibits ERK dimerization without affecting phosphorylation or kinase activity. Suppresses growth of tumor cells expressing RAS-ERK oncogenes in vitro. Induces apoptosis and prevents tumor progression in vivo.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Herrero et al (2015) Small molecule inhibition of ERK dimerization prevents tumorigenesis by RAS-ERK pathway oncogenes. Cancer Cell 28 170. PMID: 26267534.
Ryan et al (2015) Targeting RAS-mutant cancers: is ERK the key? Trends Cancer 1 183. PMID: 26858988.
If you know of a relevant reference for DEL 22379 please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses DEL 22379 from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: DEL 22379, supplier, ERK, dimerization, inhibitors, inhibits, extracellular, signal, related, kinase, RAS, Tocris Bioscience, ERK products
Find multiple products by catalog number
New Products in this Area
High affinity JNK inhibitor; also inhibits HCMV replicationOrg 48762-0
Selective p38α/β inhibitor; orally bioavailable
Follow Tocris on LinkedIn
Visit our LinkedIn page for the latest Tocris news, events and updates.